Selected article for: "lv diastolic function and lv function"

Author: Tudoran, Mariana; Tudoran, Cristina; Lazureanu, Voichita Elena; Marinescu, Adelina Raluca; Pop, Gheorghe Nicusor; Pescariu, Alexandru Silvius; Enache, Alexandra; Cut, Talida Georgiana
Title: Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously Diagnosed Cardiovascular Pathology
  • Cord-id: b48u5r3h
  • Document date: 2021_3_22
  • ID: b48u5r3h
    Snippet: (1) Background: Coronavirus infection (Covid-19) has emerged as a severe medical condition, associated with high pulmonary morbidity and often with cardiovascular (CV) complications. This study aims to evidence the persistence of left ventricular (LV) systolic function (LV-SF) alterations and diastolic dysfunction (DD) in COVID-19 patients without history of cardiovascular (CV) diseases by transthoracic echocardiography (TTE). (2) Methods: 125 patients, aged under 55 years, hospitalized during t
    Document: (1) Background: Coronavirus infection (Covid-19) has emerged as a severe medical condition, associated with high pulmonary morbidity and often with cardiovascular (CV) complications. This study aims to evidence the persistence of left ventricular (LV) systolic function (LV-SF) alterations and diastolic dysfunction (DD) in COVID-19 patients without history of cardiovascular (CV) diseases by transthoracic echocardiography (TTE). (2) Methods: 125 patients, aged under 55 years, hospitalized during the first outbreak of Covid-19 for moderate pneumonia, underwent a comprehensive cardiologic examination and TTE at 6–10 weeks after discharge. Their initial in-hospital laboratory data and thorax computer tomography (TCT) were accessed from the electronic database of the hospital. (3) Results: with TTE, we documented alterations of LV-SF and DD in 8.8% of patients and in 16.8% only patterns of DD, statistically correlated with the initial levels of creatin-kinase (CK-MB) and inflammatory factors. Multivariate regression analysis evidenced that CK-MB levels, age, and body mass index (BMI) are responsible for 65% of LV-SF decrease. (4) Conclusions: Alterations of LV-SF and DD are frequent in post-acute COVID-19 infection and are responsible for the persistence of symptoms. Elevated myocardial necrosis markers during the acute phase seem to predict subsequent alteration of cardiac performance.

    Search related documents:
    Co phrase search for related documents
    • accurate evaluation and acute covid: 1, 2, 3, 4
    • accurate evaluation and acute disease: 1, 2, 3
    • accurate evaluation and acute respiratory distress syndrome: 1
    • ace inhibitor and acute covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • ace inhibitor and acute disease: 1, 2, 3, 4
    • ace inhibitor and acute infection: 1, 2, 3, 4, 5
    • ace inhibitor and acute myocarditis: 1
    • ace inhibitor and acute phase: 1
    • ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
    • ace inhibitor and long covid syndrome: 1
    • acute covid and long covid syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute covid and long term consequence: 1, 2, 3
    • acute covid and longitudinal strain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute covid and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and admission perform: 1
    • acute disease and long covid syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute disease and long term consequence: 1, 2, 3
    • acute disease and longitudinal strain: 1, 2, 3, 4, 5, 6
    • acute disease and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25